Huami Corp Invests $5 Million in Hyperfine Research D Round to Support Accelerated Application of Disruptive MRI Technology

11 Feb, 2021

Huami Corp Invests $5 Million in Hyperfine Research D Round to Support Accelerated Application of Disruptive MRI Technology
Photo by Wesson Wang on Unsplash

Huami Corp. (NYSE: HMI) has invested $5 million in Hyperfine Research’s D round of funding, which closed on February 3, 2021.
– Huami’s mission is to connect health with technology, developing both consumer and industrial health technologies.
– The company believes its miniaturization engineering expertise dovetails with efforts to miniaturize medical imaging technology which can disrupt the locations, applications and costs of medical imaging.
– Hyperfine Research is pioneering MRI imaging with its portable Swoop system, which received FDA 510(K) clearance in August of 2020.

Computer Medical Device North America
Crunchbase icon

Content report

The following text will be sent to our editors: